Additionally, it has been well reported that EMT progression is closely linked to activation of the AKT signaling pathway, and that this explains the chemotherapeutic drug resistance of several cancers including lung cancer16, breast cancer17, ovarian cancer18 and leukemia19. Here, AKT1 is linked to cancer.